Table 5.
Assessment of reported exercise variables of frequency, intensity, time, and type (FITT) in a manner that would permit intervention replication and determination if intervention met public health physical activity guidelines.44
Trial | Exercise Study Arm(s) | Frequency | Intensity | Time | Type | Total FITT Criteria Reported | Meet Current PA Guidelines (AEx|REx) |
---|---|---|---|---|---|---|---|
Randomized controlled trials of exercise as a monotherapy (Table 1) | |||||||
Doyne et al., 198738 | AEx | 3 | |||||
REx | 2 | ||||||
Singh et al., 199720 | PREx | 4 | |||||
Blumenthal et al., 199950 | AEx | 4 | |||||
Dunn et al., 200521 | AEx PHD-3d | 2 | |||||
AEx PHD-5d | 2 | ||||||
AEx LD-3d | 2 | ||||||
AEx LD-5d | 2 | ||||||
Singh et al., 200522 | HI-PREx | 4 | |||||
LO-REx | 4 | ||||||
Blumenthal et al., 200723 | AEx | 4 | |||||
Krogh et al., 201251 | AEx | 4 | |||||
Randomized controlled trials of exercise as an adjunct to psychotherapy for major depression (Table 2) | |||||||
Jacquart et al., 201452 | Psych-Walk | 2 | |||||
Oertel-Knochel et al., 201453 | AEx | 4 | |||||
Kerling et al., 201554 | AEx | 4 | |||||
Randomized controlled trials of exercise as an adjunct to pharmacotherapy for major depression (exercise combined with pharmacotherapy as a treatment arm or all subjects on stable dose of pharmacotherapy) (Table 3) | |||||||
Blumenthal et al., 199950 | AEx | 4 | |||||
Pilu et al., 200755 | PA | 2 | |||||
Mota-Pereira al., 201156 | AEx | 4 | |||||
Danielsson et al., 201457 | PA | 3 | |||||
Belvederi Murri et al., 201558 | P-AEx | 4 | |||||
NP-AEx | 4 | ||||||
Carneiro et al., 201559 | AEx | 3 | |||||
Legrand & Neff, 201660 | AEx | 4 | |||||
Salehi et al., 201661 | AEx | 4 | |||||
Siqueira et al., 201662 | AEx | 2 | |||||
Gujral et al., 201963 | AEx | 4 | |||||
Moraes et al., 202064 | PREx | 4 | |||||
NP-AEx | 4 | ||||||
Randomized controlled trials of exercise as an adjunct to standard care for major depression (Table 4) | |||||||
Martinsen et al., 198565 | AEx | 3 | |||||
Veale et al., 199266 Study 1 |
AEx | 2 | |||||
Veale et al., 199266 Study 2 |
AEx | 2 | |||||
Knubben et al., 200767 | AEx | 4 | |||||
Krogh et al., 200968 | P-AEx | 4 | |||||
PREx | 4 | ||||||
Doose et al., 201569 | AEx | 4 | |||||
Hallgren et al., 201570 | Ex | 2 | |||||
Schuch et al., 201571 | AEx | 2 | |||||
Helgadóttir et al., 201672 | Ex-Light | 3 | |||||
Ex-Mod | 3 | ||||||
Ex-Vig | 3 | ||||||
Olson et al., 201773 | AEx | 4 | |||||
Buschert et al., 201974 | AEx | 2 | |||||
Chau et al., 202075 | Ex | AEx | 3-AEx 2-REx |
AEx | |||
REx | REx | ||||||
Haussleiter et al., 202076 | Ex | 2 | |||||
La Rocque et al., 202177 | AEx | 2 | |||||
Clinical trials examining the relationship of molecular mechanisms and clinical outcomes (Table 6) | |||||||
Krogh et al., 2010161 | P-AEx | 4 | |||||
PREx | 4 | ||||||
Toups et al., 2011162 | AEx | 0 | |||||
Krogh et al., 2012;51 | AEx | 4 | |||||
Rethorst et al., 2013155 | AEx | 1 | |||||
Krogh et al. 2014152 | AEx | 0 | |||||
Krogh et al., 2014163 | AEx | 4 | |||||
Schuch et al., 2014164 | AEx | 2 | |||||
Salehi et al., 201661 | AEx | 4 | |||||
Carniero et al., 2017117 | AEx | 3 | |||||
Euteneuer et al., 2017153 | Ex | 2 | |||||
Kerling et al., 2017165 | AEx | 3 | |||||
Lavebratt et al., 2017154 | Ex-Vig | 3 | |||||
Ex-Mod | 3 | ||||||
Ex-Light | 3 | ||||||
Rahman et al., 2017166 | Ex | 2 | |||||
Gourgouvelis et al., 2018167 | Ex (AEx + REx) |
4 | AEx | ||||
REx | |||||||
Szuhany & Otto, 2020138 | Ex | 1 | |||||
Gerber et al., 2020168 | Ex | 4 | |||||
PA = physical activity; AEx = aerobic exercise; REx = resistance exercise; PREx = progressive resistance exercise; PHD = public health dose; 3d = 3 days/week; 5d = 5days/week; HI = high intensity; LO = low intensity; Psych = psychotherapy; P-AEx = progressive aerobic exercise; NP-AEx = non-progressive aerobic exercise; Ex = exercise; Ex-Vig = exercise-vigorous intensity; Ex-Mod = exercise-moderate intensity; Ex-Light = exercise-light intensity
Assessment of FITT variables
/
= sufficient/insufficient detail provided in manuscript to replicate the frequency (e.g. times per week), intensity (e.g., % heart rate reserve (AEx); % repetition maximum (REx), time (e.g., time spent exercising; time in target intensity zone), type (e.g. stationary cycling).
Assessment of intervention compliance with public health physical activity guidelines
= intervention required at least 150 minutes of moderate intensity AEx, or 75 minutes of vigorous intensity AEx, per week; and/or intervention required at least two days of REx (utilizing most muscle groups) per week.
= insufficient detail provided to determine total time and intensity; prescribed or reported time and intensity were below recommended thresholds.